WEREWOLF THERAPEUTICS INC (HOWL) Stock Price & Overview
NASDAQ:HOWL • US95075A1079
Current stock price
The current stock price of HOWL is 1.03 USD. Today HOWL is down by -0.96%. In the past month the price increased by 64.58%. In the past year, price increased by 46.48%.
HOWL Key Statistics
- Market Cap
- 49.996M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.33
- Dividend Yield
- N/A
HOWL Stock Performance
HOWL Stock Chart
HOWL Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to HOWL. When comparing the yearly performance of all stocks, HOWL is one of the better performing stocks in the market, outperforming 92.33% of all stocks.
HOWL Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to HOWL. HOWL may be in some trouble as it scores bad on both profitability and health.
HOWL Earnings
HOWL Forecast & Estimates
11 analysts have analysed HOWL and the average price target is 6.38 USD. This implies a price increase of 518.93% is expected in the next year compared to the current price of 1.03.
HOWL Groups
Sector & Classification
HOWL Financial Highlights
Over the last trailing twelve months HOWL reported a non-GAAP Earnings per Share(EPS) of -1.33. The EPS increased by 18.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -91.48% | ||
| ROE | -245.97% | ||
| Debt/Equity | 0.73 |
HOWL Ownership
HOWL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 365.463B | ||
| AMGN | AMGEN INC | 14.88 | 184.669B | ||
| GILD | GILEAD SCIENCES INC | 15.71 | 173.96B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.27 | 110.325B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.26 | 80.669B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.98 | 43.81B | ||
| INSM | INSMED INC | N/A | 35.309B | ||
| NTRA | NATERA INC | N/A | 29.036B | ||
| BIIB | BIOGEN INC | 10.81 | 25.293B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.92 | 24.53B | ||
| MRNA | MODERNA INC | N/A | 19.261B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.898B | ||
| INCY | INCYTE CORP | 12.28 | 18.878B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HOWL
Company Profile
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is headquartered in Watertown, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2021-04-30. The company is leveraging its PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. The Company’s advanced clinical-stage product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and IL-12 INDUKINE molecules for the treatment of solid tumors. The company is advancing WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company is advancing WTX-712, WTX-518, and WTX-921 through preclinical development.
Company Info
IPO: 2021-04-30
WEREWOLF THERAPEUTICS INC
200 Talcott Avenue, 2nd Floor
Watertown MASSACHUSETTS 02138 US
CEO: Daniel J. Hicklin
Employees: 46
Phone: 16179520555
WEREWOLF THERAPEUTICS INC / HOWL FAQ
What does WEREWOLF THERAPEUTICS INC do?
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is headquartered in Watertown, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2021-04-30. The company is leveraging its PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. The Company’s advanced clinical-stage product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and IL-12 INDUKINE molecules for the treatment of solid tumors. The company is advancing WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company is advancing WTX-712, WTX-518, and WTX-921 through preclinical development.
What is the stock price of WEREWOLF THERAPEUTICS INC today?
The current stock price of HOWL is 1.03 USD. The price decreased by -0.96% in the last trading session.
Does HOWL stock pay dividends?
HOWL does not pay a dividend.
What is the ChartMill technical and fundamental rating of HOWL stock?
HOWL has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the GICS sector and industry of HOWL stock?
WEREWOLF THERAPEUTICS INC (HOWL) operates in the Health Care sector and the Biotechnology industry.
How is the valuation of WEREWOLF THERAPEUTICS INC (HOWL) based on its PE ratio?
WEREWOLF THERAPEUTICS INC (HOWL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.33).
Who owns WEREWOLF THERAPEUTICS INC?
You can find the ownership structure of WEREWOLF THERAPEUTICS INC (HOWL) on the Ownership tab.